Share on LinkedInShare on LinkedIn

ARTICLE · 08 NOVEMBER 2017

Federal Circuit Patent Updates - November 2017

WilmerHale
WilmerHale
Contributor
WilmerHale

WilmerHale

WilmerHale's London office was established more than 40 years ago. With lawyers qualified in the...

View firm profile
Explore more from WilmerHale

Bayer Pharma AG v. Watson Laboratories, Inc. (No. 2016-2169, 11/1/17) (Lourie, Moore, O'Malley) and Two-Way Media Ltd. v. Comcast Cable Communications (No. 2016-2531, 11/1/17) (Lourie, Reyna, Hughes)

United StatesIntellectual Property

View previous updates...

Bayer Pharma AG v. Watson Laboratories, Inc. (No. 2016-2169, 11/1/17) (Lourie, Moore, O'Malley)

November 1, 2017 2:08 PM

Moore, J. Reversing finding of nonobviousness and holding claims invalid as obvious. "[T]he district court clearly erred in finding a skilled artisan would not have been motivated to use the claim elements." "The motivation to combine inquiry is not limited to what products are forthcoming or currently available on the market. Particularly given the lengthy FDA approval process, the pharmaceutical industry is no exception. Any motivation, 'whether articulated in the references themselves or supported by evidence of the knowledge of skilled artisan, is sufficient'." "[T]he teaching away inquiry does not focus on whether a person of ordinary skill in the art would have merely favored one disclosed option over another disclosed option. In assessing whether prior art teaches away, that 'better alternatives

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from